Expanding the clinical spectrum of mutations.

Mol Genet Metab Rep

Fédération de Génétique et Institut Imagine, Université Paris Descartes, Hôpital Necker Enfants Malades, Paris.

Published: December 2019

We report on a m.586G > A mutation in a 14 yrs old boy with non-progressive muscle weakness, myalgia, normal brain MRI, normal schooling and absent central nervous system involvement. The same m.586G > A mutation has been previously reported in a 57 yrs-old woman with a progressive neurodegenerative disorder, akinesia-rigidity, abnormal movements, dementia, and psychiatric disorder. Those two strikingly different clinical presentations emphasize the impact of either mitochondrial factors (heteroplasmy, mitotic segregation) or hitherto unknown nuclear factors on the clinical expression of genetically homogeneous mtDNA mutations.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706677PMC
http://dx.doi.org/10.1016/j.ymgmr.2019.100501DOI Listing

Publication Analysis

Top Keywords

m586g > a mutation
8
expanding clinical
4
clinical spectrum
4
spectrum mutations
4
mutations report
4
report m586g > a
4
mutation 14 yrs
4
14 yrs boy
4
boy non-progressive
4
non-progressive muscle
4

Similar Publications

The protein therapeutics market, including antibody and fusion proteins, has experienced steady growth over the past decade, underscoring the importance of optimizing amino acid sequences. In our previous study, we developed a fusion protein, R31, which combines retinol-binding protein (RBP) with albumin domains IIIA and IB, linked by a sequence (AAAA), and includes an additional disulfide bond (N227C-V254C) in IIIA. This fusion protein effectively inhibited hepatic stellate cell activation.

View Article and Find Full Text PDF

Little information is available on how rhizosphere bacteria affect abscisic acid (ABA) levels in plants and whether these bacterial effects are associated with improved plant water status. In this study, we tested the hypothesis that the stimulation of plant growth may be associated with the ability of ABA to increase the hydraulic conductivity of roots through the up-regulation of aquaporin. To do this, we studied the effect of bacteria capable of producing ABA on a barley mutant deficient in this hormone.

View Article and Find Full Text PDF

Cytochrome (CytC), a one-electron carrier, transfers electrons from complex to cytochrome oxidase (CcO) in the electron-transport chain. Electrostatic interaction with the partners, complex and CcO, is ensured by a lysine cluster near the heme forming the Universal Binding Site (UBS). We constructed three mutant variants of mitochondrial CytC with one (2Mut), four (5Mut), and five (8Mut) Lys->Glu substitutions in the UBS and some compensating Glu->Lys substitutions at the periphery of the UBS for charge compensation.

View Article and Find Full Text PDF

Optimizing the Amino Acid Sequence Enhances the Productivity and Bioefficacy of the RBP-Albumin Fusion Protein.

Bioengineering (Basel)

June 2024

Department of Biomedical Sciences, College of Medicine, Korea University, Seoul 02841, Republic of Korea.

The significant growth of the global protein drug market, including fusion proteins, emphasizes the crucial role of optimizing amino acid sequences to enhance the productivity and bioefficacy. Among these fusion proteins, RBP-IIIA-IB, comprising retinol-binding protein in conjunction with the albumin domains, IIIA and IB, has displayed efficacy in alleviating liver fibrosis by inhibiting the activation of hepatic stellate cells (HSCs). This study aimed to address the issue of the low productivity in RBP-IIIA-IB.

View Article and Find Full Text PDF
Article Synopsis
  • The sodium leak channel (NALCN) is distinct from traditional voltage-gated channels like Na and Ca channels, having blocked openings that prevent lipophilic compounds from modulating its function.
  • Experiments showed that changing specific amino acids in NALCN allowed researchers to study how certain blockers, like phenytoin and 2-APB, interact differently with the channel, revealing unique pathways for drug access.
  • These findings enhance our understanding for future drug design aimed at targeting NALCN specifically, despite its overall resistance to pharmacological manipulation.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!